Ocuphire Pharma, Inc.
SEC Filing List
OCUP CIK: 0001228627
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Gagnon Robert E. | SIDLEY AUSTIN LLP /FA/ | 07/27/2026 | |
| 4 | Statement of changes in beneficial owner... | Yerxa Benjamin R | SIDLEY AUSTIN LLP /FA/ | 07/27/2026 | |
| 4 | Statement of changes in beneficial owner... | Schachle Joseph K | SIDLEY AUSTIN LLP /FA/ | 07/27/2026 | |
| 4 | Statement of changes in beneficial owner... | Magrath George | SIDLEY AUSTIN LLP /FA/ | 07/27/2026 | |
| 144 | Filing for proposed sale of securities u... | JEFFERIES LLC/FA | 07/23/2026 | ||
| 144 | Filing for proposed sale of securities u... | Raymond James & Associates, Inc./FA | 07/23/2026 | ||
| 144 | Filing for proposed sale of securities u... | JEFFERIES LLC/FA | 07/23/2026 | ||
| 144 | Filing for proposed sale of securities u... | Raymond James & Associates, Inc./FA | 07/23/2026 | ||
| 424B2 | Prospectus filed pursuant to Rule 424(b)(2) | Opus Genetics, Inc. | Broadridge Financial Solutions, Inc. /fa | 06/17/2026 | |
| 424B2 | Prospectus filed pursuant to Rule 424(b)(2) | Opus Genetics, Inc. | Broadridge Financial Solutions, Inc. /fa | 06/17/2026 | |
| No record found. | |||||
| Load More | |||||
